VANCOUVER, BC — October 31, 2025 — Leads & Copy — Onco-Innovations Limited (CBOE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) has appointed Jared Rushton to its Board of Directors, effective immediately.
Mr. Rushton brings over a decade of experience in the public markets and will replace Zachary Stadnyk, who has stepped down from the Board. The Company extends its gratitude to Mr. Stadnyk for his dedication and contributions during his tenure.
The Company also announced the engagement of MCS Market Communication Service GmbH for online marketing services, including campaign creation, production of marketing materials, research and analytics.
The services are expected to run until December 15, 2025, or budget exhaustion. The Company has paid MCS EUR 600,000 as consideration for its services. The services will be executed via digital channels, including Google Ads and native advertising.
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology, pursuing the prevention and treatment of cancer through pioneering research and innovative solutions and has secured an exclusive worldwide license to patented technology that targets solid tumours.
Thomas O’Shaughnessy is the Chief Executive Officer and can be reached at + 1 888 261 8055 or investors@oncoinnovations.com.
Source: Onco-Innovations Limited
